GO:0043921 host-mediated perturbation of viral transcription: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0043921 describes how a host organism alters or subverts viral transcription, a key battleground in infection and immunity.
• Host-mediated perturbation can occur through direct targeting of viral transcription machinery or by modulating host signaling pathways that viruses hijack.
• Human cytomegalovirus (HCMV) provides a well-studied example: it downregulates epidermal growth factor receptor (EGFR) and tumor necrosis factor alpha receptor (TNFR) to disrupt host signaling.
• Dysregulation of this process influences viral latency, reactivation, and pathogenesis, making it relevant to antiviral drug and vaccine development.
• CRISPR knockout, knock-in, and overexpression models enable causal dissection of host genes that perturb viral transcription.
• Understanding GO:0043921 aids identification of host-directed antiviral targets and biomarkers of infection outcome.
Description
Host-mediated perturbation of viral transcription (GO:0043921) is a biological process in which a host organism actively alters or subverts the transcription of viral genes. This term captures the interplay between host cellular machinery and viral gene expression, a critical determinant of infection outcome. Viruses rely on host factors for efficient transcription, and hosts have evolved mechanisms to interfere with this dependency, thereby limiting viral replication. Conversely, viruses can manipulate host signaling to create a favorable environment, and the host may counter by perturbing viral transcription. Understanding this process is essential for virology, immunology, and antiviral therapeutics. For example, human cytomegalovirus (HCMV) infection inhibits epidermal growth factor (EGF) signaling by targeting EGF receptors, which can indirectly affect viral transcription. Similarly, HCMV inhibits tumor necrosis factor alpha (TNF-alpha) signaling by targeting the 55-kilodalton TNF-alpha receptor, further illustrating host-mediated perturbation. These interactions highlight the complexity of host-pathogen arms races at the transcriptional level. Researchers studying GO:0043921 aim to identify host factors that restrict viral transcription, which could be exploited for host-directed antivirals. Moreover, this term is relevant to understanding viral latency, reactivation, and pathogenesis. As such, GO:0043921 serves as a framework for investigating how hosts modulate viral gene expression and how viruses evade these defenses.
host-mediated perturbation of viral transcription At A Glance
| GO ID | GO:0043921 |
|---|---|
| GO term | host-mediated perturbation of viral transcription |
| Ontology | biological_process |
| Synonym | modulation by host of viral transcription; regulation by host of viral transcription; regulation of viral transcription by host |
| Major function | Host-driven alteration or subversion of viral transcription |
| Organism level | Host-pathogen interaction |
| Related processes | Viral transcription, host immune response, signal transduction |
| Example viruses | Human cytomegalovirus (HCMV), other DNA and RNA viruses |
| Key host factors | EGFR, TNFR, and other signaling molecules |
What Is GO:0043921?
GO:0043921, host-mediated perturbation of viral transcription, is defined as a process in which a host organism alters or subverts viral transcription. This includes any host-driven mechanism that modulates the initiation, elongation, or termination of viral RNA synthesis, often through direct interaction with viral components or by interfering with host signaling pathways that viruses exploit. Synonyms include modulation by host of viral transcription, regulation by host of viral transcription, and regulation of viral transcription by host.
Why Is host-mediated perturbation of viral transcription Important in Cell Biology?
GO:0043921 is important because it represents a fundamental layer of host defense and viral counter-defense. By perturbing viral transcription, hosts can limit viral replication and spread, while viruses can manipulate host signaling to enhance their own gene expression. This process influences the outcome of infections, including latency and reactivation, and is relevant to diseases caused by viruses such as HCMV. Understanding the molecular players involved can reveal targets for host-directed antiviral therapies and inform vaccine design. Furthermore, dysregulation of host-mediated perturbation may contribute to viral pathogenesis and immune evasion, making it a key area of research in infectious diseases and immunology.
• Determines viral replication efficiency and infection outcome.
• Influences viral latency and reactivation, particularly for herpesviruses like HCMV.
• Provides targets for host-directed antiviral therapies.
• Relevant to immune evasion and pathogenesis.
• Helps explain how viruses manipulate host signaling pathways.
• Aids in understanding viral tropism and disease severity.
• Can inform vaccine development by identifying host factors that restrict viral transcription.
• Links to broader processes like cell signaling, apoptosis, and inflammation.
• Enables discovery of biomarkers for viral disease progression.
• Facilitates comparative studies across different viruses and hosts.
What Happens During host-mediated perturbation of viral transcription?
Host recognition of viral infection
In simple terms: The host cell detects the presence of a virus and triggers defense responses.
Upon viral entry, host pattern recognition receptors detect viral components, leading to activation of signaling cascades that can ultimately perturb viral transcription. For example, HCMV infection triggers host responses that target viral gene expression, although the virus can also counteract these defenses.
Modulation of host signaling pathways
In simple terms: The host interferes with signaling pathways that viruses need for efficient transcription.
Host-mediated perturbation often involves altering key signaling pathways. HCMV infection inhibits epidermal growth factor (EGF) signaling by targeting EGF receptors, which can affect viral transcription indirectly. Similarly, HCMV inhibits TNF-alpha signaling by targeting the 55-kilodalton TNF-alpha receptor, further demonstrating host-mediated interference with pathways that viruses may exploit.
Direct targeting of viral transcription machinery
In simple terms: Host proteins can directly bind to and inhibit viral transcription factors or RNA polymerase.
Host cells may produce factors that directly interact with viral transcription complexes, preventing efficient viral RNA synthesis. While specific examples are still being elucidated, the general principle is that host restriction factors can block viral transcription elongation or initiation.
Viral counter-defense and evasion
In simple terms: Viruses fight back by evading or counteracting host perturbations.
Viruses have evolved mechanisms to overcome host-mediated perturbation. For instance, HCMV can downregulate host receptors to prevent antiviral signaling, thereby preserving its own transcription. This arms race shapes the co-evolution of host and virus.
Outcome: restriction or persistence
In simple terms: The balance between host perturbation and viral evasion determines whether the virus is controlled or persists.
The net result of host-mediated perturbation of viral transcription can be either successful restriction of viral replication or establishment of latency/persistence. In HCMV, the interplay between host signaling inhibition and viral countermeasures influences latency and reactivation.
Key Genes Involved in GO:0043921 host-mediated perturbation of viral transcription
The following genes and proteins are key players in host-mediated perturbation of viral transcription, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EGFR | Host receptor targeted by HCMV to inhibit EGF signaling | Model to study how viral targeting of growth factor receptors perturbs transcription |
| TNFRSF1A | 55-kDa TNF-alpha receptor targeted by HCMV to inhibit TNF-alpha signaling | Key node in inflammatory signaling that affects viral transcription |
| IFIH1 | Cytosolic sensor of viral RNA, activates interferon response | Potential upstream regulator of host-mediated perturbation |
| MAVS | Mitochondrial antiviral signaling adaptor | Links innate sensing to transcriptional changes |
| IRF3 | Transcription factor activated by viral infection | Drives interferon-stimulated genes that can perturb viral transcription |
| IRF7 | Master regulator of type I interferon response | Amplifies antiviral transcriptional programs |
| STAT1 | Signal transducer and activator of transcription | Mediates interferon signaling to perturb viral transcription |
| NFKB1 | NF-kB subunit, regulates immune and inflammatory genes | Modulates transcription of antiviral effectors |
| RELA | NF-kB subunit, pleiotropic transcription factor | Involved in host response to viral infection |
| JAK1 | Janus kinase, mediates cytokine signaling | Part of JAK-STAT pathway that can perturb viral transcription |
| JAK2 | Janus kinase, mediates cytokine signaling | Part of JAK-STAT pathway that can perturb viral transcription |
| TYK2 | Tyrosine kinase, mediates cytokine signaling | Part of JAK-STAT pathway that can perturb viral transcription |
| IFNA1 | Type I interferon, induces antiviral state | Directly perturbs viral transcription via ISGs |
| IFNB1 | Type I interferon, induces antiviral state | Directly perturbs viral transcription via ISGs |
| OAS1 | Interferon-induced antiviral enzyme | Degrades viral RNA, indirectly affecting transcription |
| PKR | Interferon-induced kinase, inhibits translation | Can indirectly perturb viral transcription via translation inhibition |
| ISG15 | Ubiquitin-like modifier, antiviral | Modifies host and viral proteins to perturb viral transcription |
| ADAR | RNA editing enzyme, interferon-induced | Can alter viral RNA and transcription |
How Is host-mediated perturbation of viral transcription Regulated?
The process of host-mediated perturbation of viral transcription is regulated by multiple layers of host signaling. Key pathways include the interferon response, which induces hundreds of interferon-stimulated genes (ISGs) that can directly or indirectly inhibit viral transcription. The JAK-STAT pathway is central to this regulation, as it transduces signals from interferons and other cytokines to activate ISG transcription. Additionally, host-mediated perturbation can be modulated by viral proteins that target components of these pathways, as seen with HCMV targeting of EGFR and TNFR. Negative feedback loops and post-translational modifications further fine-tune the response. Understanding these regulatory mechanisms is crucial for developing therapies that enhance host restriction of viral transcription.
host-mediated perturbation of viral transcription and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EGFR | HCMV infection, EGF signaling inhibition | Knockout of EGFR in HCMV-infected cells to study viral transcription |
| TNFRSF1A | HCMV infection, TNF-alpha signaling inhibition | Point mutation in TNFRSF1A to assess viral transcription |
| IFIH1 | Innate immune sensing of viruses | Knockout to study interferon response to viral infection |
| MAVS | Antiviral signaling | Knockout to assess viral transcription upon infection |
| STAT1 | Interferon signaling, antiviral defense | Knockout to evaluate viral transcription and replication |
Human cytomegalovirus (HCMV) infection
HCMV is a prototypical example where host-mediated perturbation of viral transcription plays a critical role. HCMV infection inhibits EGF signaling by targeting EGF receptors, which can affect viral transcription and latency. Additionally, HCMV inhibits TNF-alpha signaling by targeting the 55-kDa TNF-alpha receptor, further illustrating how the virus manipulates host pathways to its advantage. These interactions contribute to HCMV pathogenesis, including congenital disabilities and immunocompromised patient complications.
Herpesvirus-associated diseases
Other herpesviruses may employ similar strategies to perturb host signaling and viral transcription. The principles learned from HCMV can be extrapolated to related viruses, informing research on diseases such as Kaposi's sarcoma and Epstein-Barr virus-associated malignancies.
Antiviral therapy and resistance
Host-mediated perturbation of viral transcription is a double-edged sword: it can restrict viral replication, but viruses can evolve resistance. Understanding these dynamics is essential for designing host-directed antivirals that are less prone to resistance.
From host-mediated perturbation of viral transcription-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does EGFR knockout affect HCMV viral transcription? | CRISPR knockout of EGFR in human fibroblasts, followed by HCMV infection and RNA-seq |
| How does point mutation in TNFRSF1A influence viral transcription? | CRISPR point mutation knock-in of TNFRSF1A variants, then measure viral RNA |
| Can overexpression of ISGs restrict viral transcription? | CRISPR overexpression of ISGs (e.g., IFIT1) in permissive cells, then infect and quantify viral transcripts |
| What is the role of MAVS in host-mediated perturbation? | MAVS knockout cells infected with RNA virus, measure viral transcription |
| Does tagged STAT1 alter its ability to perturb viral transcription? | Knock-in of tagged STAT1, then ChIP-seq for viral promoters |
| Which host factors are essential for interferon-mediated perturbation? | Genome-wide CRISPR library screening in cells treated with interferon and infected with virus |
How to Study the host-mediated perturbation of viral transcription Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Viral and host transcript abundance | Quantify viral transcription upon host gene perturbation |
| ChIP-seq | Protein-DNA interactions | Map host factor binding to viral promoters |
| Proteomics | Protein abundance and interactions | Identify host proteins interacting with viral transcription machinery |
| CRISPR knockout screening | Loss-of-function phenotypes | Discover host genes that restrict viral transcription |
| CRISPR activation screening | Gain-of-function phenotypes | Identify host genes that enhance viral transcription |
| Reporter assays | Transcriptional activity | Measure viral promoter activity in response to host factors |
| qRT-PCR | Specific viral RNA levels | Validate RNA-seq findings |
| Immunofluorescence | Protein localization | Visualize viral and host proteins during infection |
RNA sequencing (RNA-seq)
RNA-seq is a powerful method to quantify viral and host transcript levels during infection. It can reveal how host-mediated perturbation alters viral transcription globally. By comparing wild-type and knockout cells, researchers can identify host genes that restrict viral transcription.
Chromatin immunoprecipitation sequencing (ChIP-seq)
ChIP-seq can map the binding of host transcription factors or viral proteins to viral genomes, providing mechanistic insights into how host factors perturb viral transcription. This method is useful for identifying direct targets of host-mediated perturbation.
Proteomics and interactomics
Mass spectrometry-based proteomics can identify host proteins that interact with viral transcription complexes. This helps uncover the molecular machinery involved in host-mediated perturbation.
CRISPR screening
Genome-wide CRISPR knockout or activation screens can systematically identify host genes that perturb viral transcription. Cells are infected with a virus expressing a reporter, and sgRNAs that alter reporter expression are enriched.
How CRISPR Can Be Used to Study GO:0043921 host-mediated perturbation of viral transcription
Knockout
CRISPR knockout is used to delete host genes suspected of perturbing viral transcription. For example, knocking out EGFR or TNFRSF1A can reveal their roles in HCMV-mediated perturbation. Knockout cell lines are infected with virus, and viral transcription is quantified by RNA-seq or qRT-PCR.
Point Mutation
Point mutations can be introduced to model specific amino acid changes in host proteins that affect their function. For instance, mutating phosphorylation sites in STAT1 can test its role in perturbing viral transcription. These models help dissect signaling events.
Knock-in
Knock-in of tagged or reporter genes allows tracking of host proteins during infection. Tagging endogenous EGFR or TNFR can reveal their trafficking and interactions with viral components. This approach provides physiological expression levels.
Overexpression
Overexpression of host restriction factors can enhance perturbation of viral transcription. For example, overexpressing interferon-stimulated genes can suppress viral transcription. This is useful for gain-of-function studies and identifying antiviral effectors.
How EDITGENE Supports host-mediated perturbation of viral transcription Research
Researchers studying host-mediated perturbation of viral transcription-related genes often need to determine whether a candidate gene is causally involved in restricting or enhancing viral transcription. This requires precise genetic models that can knockout, mutate, tag, or overexpress the gene of interest in relevant cell types. EDITGENE provides a comprehensive suite of CRISPR services to accelerate such discoveries.
Contact EDITGENE today to design your custom CRISPR model for host-mediated perturbation of viral transcription research.
Frequently Asked Questions About host-mediated perturbation of viral transcription
What is GO:0043921?
GO:0043921 is the Gene Ontology term for host-mediated perturbation of viral transcription, a process where a host organism alters or subverts viral transcription.
What genes are involved in host-mediated perturbation of viral transcription?
Key genes include EGFR and TNFRSF1A, which are targeted by HCMV to inhibit host signaling and affect viral transcription. Other genes include interferon-stimulated genes and signaling molecules like STAT1.
How does HCMV perturb viral transcription?
HCMV inhibits EGF signaling by targeting EGF receptors and inhibits TNF-alpha signaling by targeting the 55-kDa TNF-alpha receptor, which can indirectly perturb viral transcription.
Why is host-mediated perturbation of viral transcription important?
It determines viral replication efficiency, influences latency and pathogenesis, and provides targets for antiviral therapies.
What methods are used to study host-mediated perturbation of viral transcription?
Common methods include RNA-seq, ChIP-seq, proteomics, and CRISPR screening to identify host factors and measure viral transcription.
Can CRISPR be used to study host-mediated perturbation of viral transcription?
Yes, CRISPR knockout, knock-in, point mutation, and overexpression models enable precise dissection of host genes involved in this process.
What diseases are associated with host-mediated perturbation of viral transcription?
Diseases include HCMV infection and other herpesvirus-associated conditions where host signaling is disrupted.
How does the host perturb viral transcription?
The host can directly target viral transcription machinery or modulate signaling pathways that viruses require, as seen with EGFR and TNFR targeting.
What is the role of EGFR in host-mediated perturbation of viral transcription?
HCMV infection targets EGFR to inhibit EGF signaling, which can affect viral transcription and contribute to pathogenesis.
What is the role of TNFRSF1A in host-mediated perturbation of viral transcription?
HCMV targets the 55-kDa TNF-alpha receptor (encoded by TNFRSF1A) to inhibit TNF-alpha signaling, thereby perturbing viral transcription.
Conclusion
GO:0043921, host-mediated perturbation of viral transcription, is a critical process at the interface of host immunity and viral pathogenesis. Studies on HCMV have revealed how targeting of EGFR and TNFR by the virus disrupts host signaling and impacts viral transcription. Understanding these mechanisms offers opportunities for host-directed antivirals and vaccines. CRISPR-based models are indispensable for dissecting the genetic basis of this process. EDITGENE provides comprehensive services to support such research, from knockout to library screening.
References
- 1. Fairley JA et al.. 2002. Human cytomegalovirus infection inhibits epidermal growth factor (EGF) signalling by targeting EGF receptors.. J Gen Virol 83(Pt 11):2803-2810 PMID: 12388817
- 2. Baillie J et al.. 2003. Human cytomegalovirus infection inhibits tumor necrosis factor alpha (TNF-alpha) signaling by targeting the 55-kilodalton TNF-alpha receptor.. J Virol 77(12):7007-16 PMID: 12768019
